Role of combined determination of troponin and copetin in diagnosis and prognosis in acute coronary syndrome with non

Abstract

This literary review are the modern data on the clinical, laboratory and instrumental diagnostics in patients with acute coronary syndrome. Presented in detail and the role of the new target biochemical marker copeptin (C-end part of the Pro-vasopressin), in the diagnosis and prognosis in patients with acute coronary syndrome (ACS) with Non-ST-Elevation. According to the literature data for acute myocardial infarction (AMI) copeptin level rises immediately after the onset of symptoms, reaching peak values during 3–4 hours and it is expected that together with copeptin measurement troponin T and I may constitute a valuable prognostic information for risk stratification and outcome in patients with Non-ST-Elevation ACS st segment elevation.